CDTX vs DEO · rev $1.3M vs P/E 16, $55.86B cap
Cidara Therapeutics Inc (CDTX) versus Diageo PLC ADR (DEO) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Diageo PLC ADR (DEO) is a beverages - wineries & distilleries company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
DEO does not have a complete income-statement cache yet.
CDTX currently screens at market cap $6.96B. DEO currently screens at market cap $55.86B and trailing P/E 15.6.
Not investment advice. Open the CDTX and DEO stock pages for the full models.
Not investment advice.